ANTX Short Interest
AN2 Therapeutics, Inc.
1W: +8.4%
1M: -22.9%
3M: -23.1%
YTD: +247.8%
1Y: +229.9%
3Y: -74.2%
$3.86
+0.23 (+6.34%)
Weekly Expected Move ±11.9%
$3
$3
$4
$4
$4
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' 6.39.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Short Volume Summary
2026-10-2675.5%
Short Ratio
of total volume
59.8%
20-Day Avg
56.8%
50-Day Avg
▲ Rising
5-Day Trend
0.0M
Short Volume
0.1M
Total Volume
Daily Short Volume Ratio
Short Volume vs Total Volume
Exchange Breakdown
2026-10-26| Exchange | Short Volume | Total Volume | Short % |
|---|---|---|---|
| NASDAQ | 47,967 | 63,892 | 75.1% |
| NYSE | 1,959 | 2,235 | 87.7% |
| BATS | 2 | 2 | 100.0% |